ProBioGen and Spica Therapeutics Announce Collaboration on GlymaxX-Enhanced CLD for Spica’s Clinical Development Candidate ST101 BERLIN, Germany and BRUSSELS, Belgium, December 09, 2025 / Biotech ...
Once a top college, it dropped nearly 60 spots in rankings and spent twice as much per student as its peers. Here's what ...
Newspoint on MSN
CBSE important notice: Rules changed for class 10 board exams, answer sheets must be written as per new guidelines
The CBSE board has issued an important notice for all students appearing for the Class 10 board exams in 2026, stating that significant changes have been made to the question papers for both Science ...
Zealand Pharma targets five launches, +10 clinical pipeline programs, and industry-leading cycle times from idea to clinic by 2030 Catalyst-rich 2026 with multiple clinical readouts, including Phase 2 ...
Under the partnership, Phare Bio will deploy its Generative AI platform to design molecules with antibacterial properties that meet a pre-defined target product profile, which considers both unmet ...
Palatin Technologies shares rose in after-hours trading as Janus Henderson Group and its subsidiary reported shared ownership of the company's stock.
Touchstone Mid Cap Growth Fund outperformed its benchmark in Q3 2025 despite speculative markets. Discover key drivers and ...
You can pursue careers in banking, finance and insurance, education, armed forces, even scientific areas like agriculture, ...
The preparation strategies have started to toll in as the Class 12 Science CBSE Board Exam 2026 is coming nearer. According ...
Global convertible bonds returned 9.1% in Q3 and 18.5% YTD amid 'Goldilocks' conditions. Read the full report to discover key ...
The CBSE Class 10 and Class 12 board examinations will begin on February 17. The Class 10 exams will end on March 10, while Class 12 exams will conclude on April 9. Ahead of the board exams, CBSE ...
Merck’s Keytruda, the category-defining CPI, reported $29.5 billion in revenue in 2024, with NSCLC representing an estimated 30% of its total sales. Keytruda is expected to approach $35 billion by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results